Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

American College Of Cardiology 2006 Meeting In Brief

This article was originally published in The Gray Sheet

Executive Summary

Drug-eluting stent study looks at long lesions: Johnson & Johnson/Cordis claimed victory for its Cypher stent over Boston Scientific's Taxus in the treatment of long, complex lesions, based on results of its LONG DES-II trial presented at the American College of Cardiology meeting in Atlanta on March 12. Six months after randomizing 500 patients with lesions greater than 25 mm to either Cypher or Taxus, investigators at the University of Ulsan, Seoul, Korea recorded less in-stent late loss among the Cypher group (0.05 mm +0.22 mm lumen diameter loss index for Cypher, versus 0.25 mm +0.35 mm for Taxus). Investigators also recorded 71% less in-segment restenosis for the Cypher group compared to Taxus...
Advertisement

Related Content

TCT In Brief
TCT In Brief
New Cypher PMA filed
New Cypher PMA filed
Medtronic Misses Endeavor Primary Endpoint, But Claims PMA Still On Track
Medtronic Misses Endeavor Primary Endpoint, But Claims PMA Still On Track
Advertisement
UsernamePublicRestriction

Register

MT023326

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel